Brief: Xencor, Morphosys And Incyte Enter Into Global Development Collaboration
11/11/2020 21:17
Nov 11 (Reuters) - Incyte Corp INCY.O :
* XENCOR, MORPHOSYS AND INCYTE ENTER INTO GLOBAL DEVELOPMENT
COLLABORATION FOR TAFASITAMAB IN COMBINATION WITH PLAMOTAMAB
Source text for Eikon: ID:nBw1ZD0Pla
Further company coverage: INCY.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Xencor
See all newsXencor, Inc. reports results for the quarter ended June 30 - Earnings Summary
Biopharma firm Xencor's Q2 revenue beats on royalty revenue, milestone payments
Brief: Xencor Q2 EPS USD -0.29
Brief: Xencor To Receive $105 Million From Alexion To Resolve Ultomiris® U.S. Royalty Matter
Xencor Q1 revenue falls sharply and misses estimates